« Back to Record
Overman, M. J., Hill, A., Sawyer, M. M., Hendlisz, A., Neyns, B., Svrcek, M., Moss, R. R., Ledeine, J. M., Cao, A. Z., Kamble, S., Kopetz, S., Lonardi, S., André, T., Wong, K. Y. M., Lenz, H.-J., Gelsomino, F., Aglietta, M., Morse, M. M., Van Cutsem, E., & McDermott, R. (2018). Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. Journal of clinical oncology, 36(8), 773-779. doi:10.1200/JCO.2017.76.9901
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/269547



